UBS Group

UBS Group’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

UBS Group’s Portfolio VAXX Stock Details VAXX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$30.7K	Sell
2023 Q4	$36.6K	Buy
2023 Q3	$12.8K	Sell
2023 Q2	$62.9K	Buy
2023 Q1	$6.05K	Buy
2022 Q4	$1.78K	Sell
2022 Q3	$12K	Buy
2022 Q1	–	Sell
2021 Q4	$14K	Buy